ChemChina says Syngenta deal
filing accepted by Beijing
Send a link to a friend
[March 06, 2017]
By Chen Aizhu
BEIJING
(Reuters) - ChemChina [CNNCC.UL] said on Monday that Beijing had
accepted its application for regulatory approval of its $43 billion
takeover of Syngenta last month.
Earlier Gao Hucheng, who retired as commerce minister less than two
weeks ago, said the government had not received a formal filing for
China's largest overseas acquisition.
Speaking to Reuters on the sidelines of parliament's annual meeting, Gao
also said the Ministry of Commerce (MOFCOM) would not start considering
any submission until regulators in other countries had given the deal
the green light.
Responding to the comments, ChemChina spokesman Ren Kan denied this,
saying by phone the company had submitted the application and the
ministry had accepted it.
A second company official who was not authorized to speak to press, said
the ministry's anti-trust bureau had accepted the application on Feb 9.
It is not clear if Gao, who left his post and was replaced by his deputy
on Feb 23, had not been briefed with the most up-to-date information.
Gao is now a senior member of a largely ceremonial but high-profile
advisory body to parliament.

Press officials at the Ministry of Commerce were not immediately
available for comment, while Syngenta did not immediately respond to a
request for comment.
Gao's comments come a month after Syngenta delayed the expected closure
of the deal to the second quarter amid scrutiny from U.S. and European
regulators.
His remarks will likely stir fresh speculation among Syngenta investors
about the China regulatory process.
[to top of second column] |

China's Commerce Minister Gao Hucheng attends a session during the
2016 G20 Trade Ministers Meeting in Shanghai, China July 10, 2016.
REUTERS/Aly Song

Mergermarket publication PaRR reported in January that ChemChina had previously
filed and then withdrawn the filing, a strategy that is sometimes used to give
merging parties more time for the deal to clear, or to address potential
objections.
Last month, Syngenta Chief Executive Erik Fyrwald did not confirm if China's
Commerce Ministry had formally accepted a filing, but said he was confident the
deal would win approval in the world's top agricultural market, without any long
delays.
The process has drawn intense interest from investors as Bayer's <BAYGn.DE>
acquisition of Monsanto <MON.N> and the merger of Dow Chemical <DOW.N> and
DuPont <DD.N> are being examined by regulators across the globe.
Mario Russo, an analyst at boutique investment bank NSBO said the deal created
few overlaps outside Europe and he expected Chinese regulators to approve the
deal, which is strategically important to China, once the U.S. and EU had
officially cleared it.
However, investors had concerns over potential domestic political interference
that could potentially slow the deal and wanted more transparency on the
timetable, he added.
(Additional reporting by Michelle Price; Writing by Josephine Mason; Editing by
Christian Schmollinger/Tom Hogue/Alexander Smith)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |